Prime Therapeutics buying Magellan Health's pharma business for $1.35 billion
May 05, 2022 at 12:33 PM EDT
Prime Therapeutics said the deal will lower costs by creating a new specialty drug-management model.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.